A case of renal thrombotic microangiopathy caused by Bevacizumab
<正>病例资料患者,男性,36岁,因"发现皮肤斑块2年余,双下肢水肿3月余"于2018年3月12日入院。患者于2016年2月出现颈部及胸部皮肤斑块并进行性扩大,2017年4月于外院行皮肤活检明确诊断"淋巴结外NK/T细胞淋巴瘤"。2017年6月起予"贝伐珠单抗(500 mg静滴)联合吉西他滨(1.8 g静滴)、奥沙利铂(200 mg静滴)、培门冬酶(3 750 IU肌肉注射)及地塞米松(10 mg静滴)"化疗,每月1疗程,共8疗程,同时予对症支持治疗,2018年1月22化疗结束。化...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2020-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57909557&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850187111001489408 |
|---|---|
| author | LIAO Bing LI Jian-bo QIU Ya-gui ZHANG Di-hua YANG Shi-cong YE Zi-yin CHEN Wen-fang HUANG Feng-xian |
| author_facet | LIAO Bing LI Jian-bo QIU Ya-gui ZHANG Di-hua YANG Shi-cong YE Zi-yin CHEN Wen-fang HUANG Feng-xian |
| author_sort | LIAO Bing |
| collection | DOAJ |
| description | <正>病例资料患者,男性,36岁,因"发现皮肤斑块2年余,双下肢水肿3月余"于2018年3月12日入院。患者于2016年2月出现颈部及胸部皮肤斑块并进行性扩大,2017年4月于外院行皮肤活检明确诊断"淋巴结外NK/T细胞淋巴瘤"。2017年6月起予"贝伐珠单抗(500 mg静滴)联合吉西他滨(1.8 g静滴)、奥沙利铂(200 mg静滴)、培门冬酶(3 750 IU肌肉注射)及地塞米松(10 mg静滴)"化疗,每月1疗程,共8疗程,同时予对症支持治疗,2018年1月22化疗结束。化 |
| format | Article |
| id | doaj-art-bf6701fb534c4a69917dd2ab672defb9 |
| institution | OA Journals |
| issn | 1671-2390 |
| language | zho |
| publishDate | 2020-01-01 |
| publisher | Editorial Department of Journal of Clinical Nephrology |
| record_format | Article |
| series | Linchuang shenzangbing zazhi |
| spelling | doaj-art-bf6701fb534c4a69917dd2ab672defb92025-08-20T02:16:10ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902020-01-0134835057909557A case of renal thrombotic microangiopathy caused by BevacizumabLIAO BingLI Jian-boQIU Ya-guiZHANG Di-huaYANG Shi-congYE Zi-yinCHEN Wen-fangHUANG Feng-xian<正>病例资料患者,男性,36岁,因"发现皮肤斑块2年余,双下肢水肿3月余"于2018年3月12日入院。患者于2016年2月出现颈部及胸部皮肤斑块并进行性扩大,2017年4月于外院行皮肤活检明确诊断"淋巴结外NK/T细胞淋巴瘤"。2017年6月起予"贝伐珠单抗(500 mg静滴)联合吉西他滨(1.8 g静滴)、奥沙利铂(200 mg静滴)、培门冬酶(3 750 IU肌肉注射)及地塞米松(10 mg静滴)"化疗,每月1疗程,共8疗程,同时予对症支持治疗,2018年1月22化疗结束。化http://www.lcszb.com/thesisDetails?columnId=57909557&Fpath=home&index=0贝伐珠单抗血栓性微血管病肾损害 |
| spellingShingle | LIAO Bing LI Jian-bo QIU Ya-gui ZHANG Di-hua YANG Shi-cong YE Zi-yin CHEN Wen-fang HUANG Feng-xian A case of renal thrombotic microangiopathy caused by Bevacizumab Linchuang shenzangbing zazhi 贝伐珠单抗 血栓性微血管病肾损害 |
| title | A case of renal thrombotic microangiopathy caused by Bevacizumab |
| title_full | A case of renal thrombotic microangiopathy caused by Bevacizumab |
| title_fullStr | A case of renal thrombotic microangiopathy caused by Bevacizumab |
| title_full_unstemmed | A case of renal thrombotic microangiopathy caused by Bevacizumab |
| title_short | A case of renal thrombotic microangiopathy caused by Bevacizumab |
| title_sort | case of renal thrombotic microangiopathy caused by bevacizumab |
| topic | 贝伐珠单抗 血栓性微血管病肾损害 |
| url | http://www.lcszb.com/thesisDetails?columnId=57909557&Fpath=home&index=0 |
| work_keys_str_mv | AT liaobing acaseofrenalthromboticmicroangiopathycausedbybevacizumab AT lijianbo acaseofrenalthromboticmicroangiopathycausedbybevacizumab AT qiuyagui acaseofrenalthromboticmicroangiopathycausedbybevacizumab AT zhangdihua acaseofrenalthromboticmicroangiopathycausedbybevacizumab AT yangshicong acaseofrenalthromboticmicroangiopathycausedbybevacizumab AT yeziyin acaseofrenalthromboticmicroangiopathycausedbybevacizumab AT chenwenfang acaseofrenalthromboticmicroangiopathycausedbybevacizumab AT huangfengxian acaseofrenalthromboticmicroangiopathycausedbybevacizumab AT liaobing caseofrenalthromboticmicroangiopathycausedbybevacizumab AT lijianbo caseofrenalthromboticmicroangiopathycausedbybevacizumab AT qiuyagui caseofrenalthromboticmicroangiopathycausedbybevacizumab AT zhangdihua caseofrenalthromboticmicroangiopathycausedbybevacizumab AT yangshicong caseofrenalthromboticmicroangiopathycausedbybevacizumab AT yeziyin caseofrenalthromboticmicroangiopathycausedbybevacizumab AT chenwenfang caseofrenalthromboticmicroangiopathycausedbybevacizumab AT huangfengxian caseofrenalthromboticmicroangiopathycausedbybevacizumab |